drugset / Trial / NCT02737891
Safety and Efficacy Study of Tesofensine/Metoprolol Treatment in Subjects With Type 2 Diabetes Mellitus
RandomizedParallel-groupDouble-blindTreatment
Summary
Safety and Efficacy Study of Tesofensine/Metoprolol Treatment in Subjects With Type 2 Diabetes Mellitus
Timeline
- Start
- 2016-04
- Primary completion
- 2017-01
- Completion
- 2017-03
Outcome
Met primary endpoint
registry analysis (superiority test); Tesofensine/Metoprolol vs Placebo; p = 0.004; Mean Difference (Net) -3.8 (95% CI -6.36 to -1.29) NCT02737891 ↗
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Metoprolol | Other / unclassified | 100 mg | Oral |
| Subject | Tesofensine | Small molecule | 0.5 mg | Oral |